Bioequivalence Study Requirements for BCS Class I Drugs: A Regulatory Perspective
Bioequivalence Study Requirements for BCS Class I Drugs: A Regulatory Perspective Regulatory Expectations for Bioequivalence in BCS Class I Drugs Introduction to BCS Class I and Regulatory Implications The Biopharmaceutics Classification System (BCS) classifies drug substances based on solubility and intestinal permeability. BCS Class I drugs are characterized by high solubility and high permeability, making…
Read More “Bioequivalence Study Requirements for BCS Class I Drugs: A Regulatory Perspective” »